Evidence map›Paper›PMID 28388439›Full record

ArticleMolecular cell2017

Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy.

Mengjie Hu, Qiang Luo, Gulimiran Alitongbieke, Shuyi Chong, Chenting Xu, Lei Xie, Xiaohui Chen, Duo Zhang, Yuqi Zhou, Zhaokai Wang and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 170 papers.

0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

170 citing papers in PubMed, 313 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Regulation and roles of mammalian mitophagy.Nature reviews. Molecular cell biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in pharmacology · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 2 countries.

Mengjie HuSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Qiang LuoEngineering Research Center of Marine Biological Resource Comprehensive Utilization, Third Institute of Oceanography, China State Oceanic Administration, Xiamen 361005, China.
Gulimiran AlitongbiekeSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Shuyi ChongSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Chenting XuSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Lei XieSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Xiaohui ChenSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Duo ZhangSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Yuqi ZhouSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Zhaokai WangEngineering Research Center of Marine Biological Resource Comprehensive Utilization, Third Institute of Oceanography, China State Oceanic Administration, Xiamen 361005, China.
Xiaohong YeSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Lijun CaiSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Fang ZhangEngineering Research Center of Marine Biological Resource Comprehensive Utilization, Third Institute of Oceanography, China State Oceanic Administration, Xiamen 361005, China.
Huibin ChenBiology Department, Xiamen Ocean College, Xiamen 361102, China.
Fuquan JiangSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Hui FangEngineering Research Center of Marine Biological Resource Comprehensive Utilization, Third Institute of Oceanography, China State Oceanic Administration, Xiamen 361005, China.
Shanjun YangEngineering Research Center of Marine Biological Resource Comprehensive Utilization, Third Institute of Oceanography, China State Oceanic Administration, Xiamen 361005, China.
Jie LiuSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Maria T Diaz-MecoCancer center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Ying SuSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China; Cancer center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Hu ZhouSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China.
Jorge MoscatCancer center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Xiangzhi LinEngineering Research Center of Marine Biological Resource Comprehensive Utilization, Third Institute of Oceanography, China State Oceanic Administration, Xiamen 361005, China.
Xiao-Kun ZhangSchool of Pharmaceutical Sciences, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361102, China; Cancer center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA. Electronic address: xzhang@sbpdiscovery.org.
Xiamen University · CNFujian Institute of Oceanography · CNDiscovery Institute · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ELENA B PASQUALE · 1985 to 2026
$107.2M
The p62/MEKK3 complex in mTORC1 activationR01CA192642 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI DIAZ MECO CONDE, MARIA TERESA · 2015 to 2019
$2.2M
Protein Kinase Cz targets in Intestinal Cancer Stem CellsR01CA172025 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MOSCAT, JORGE · 2013 to 2017
$2.2M
Role of tRXRalpha in pancreatic cancer development and therapyR21CA179379 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ZHANG, XIAO-KUN · 2013 to 2014
$460k
NCI NIH HHS P30 CA030199NCI NIH HHS R01 CA172025NCI NIH HHS R01 CA192642NCI NIH HHS R21 CA179379
6 · The paper itself

Abstract

Mitochondria play an integral role in cell death, autophagy, immunity, and inflammation. We previously showed that Nur77, an orphan nuclear receptor, induces apoptosis by targeting mitochondria. Here, we report that celastrol, a potent anti-inflammatory pentacyclic triterpene, binds Nur77 to inhibit inflammation and induce autophagy in a Nur77-dependent manner. Celastrol promotes Nur77 translocation from the nucleus to mitochondria, where it interacts with tumor necrosis factor receptor-associated factor 2 (TRAF2), a scaffold protein and E3 ubiquitin ligase important for inflammatory signaling. The interaction is mediated by an LxxLL motif in TRAF2 and results not only in the inhibition of TRAF2 ubiquitination but also in Lys63-linked Nur77 ubiquitination. Under inflammatory conditions, ubiquitinated Nur77 resides at mitochondria, rendering them sensitive to autophagy, an event involving Nur77 interaction with p62/SQSTM1. Together, our results identify Nur77 as a critical intracellular target for celastrol and unravel a mechanism of Nur77-dependent clearance of inflamed mitochondria to alleviate inflammation.

Indexed as

Active Transport, Cell NucleusAnimalsAnti-Inflammatory AgentsAutophagyChemical and Drug Induced Liver InjuryDisease Models, AnimalFemaleGenotypeHEK293 CellsHeLa CellsHep G2 CellsHumansLigandsMaleMice, Inbred C57BLMice, KnockoutAnti-Inflammatory AgentscelastrolLigandsNr4a1 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 1Pentacyclic TriterpenesSequestosome-1 ProteinSqstm1 protein, mouseTNF Receptor-Associated Factor 2TRAF2 protein, mouseTriterpenesautophagyCelastrolinflammationmitochondriamitophagynuclear receptorNur77p62/SQSTM1TR3TRAF2

Identifiers

PMID28388439
PMCPMC5761061
OpenAlexW2604143793

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.